サマリー

市場分析と洞察。患者用医療製品の世界市場
患者用健康製品の世界市場規模は、2021年の百万米ドルから2028年には百万米ドルに達すると予測され、2022年から2028年の間、CAGRは%で推移します。
この健康危機による経済的変化を十分に考慮した上で、スキンケア製品は2021年の患者用医療製品世界市場の％を占めていますが、COVID-19後の期間に改訂された％のCAGRで成長し、2028年には100万米ドルになると予測されます。一方、病院薬局のセグメントは、この予測期間中、年率％で変化しています。
中国の患者用健康製品の市場規模は2021年に百万米ドル、北米と欧州の患者用健康製品の市場規模はそれぞれ百万米ドルと百万米ドルとなっています。2021年の北米の割合は%ですが、中国と欧州はそれぞれ%と%で、中国の割合は2028年に%に達し、分析期間中のCAGRは%になると予測されます。アジアでは、日本、韓国、東南アジアが注目すべき市場であり、今後6年間のCAGRはそれぞれ％、％、％となっています。欧州の患者用医薬品市場では、ドイツが2028年までに100万米ドルに達すると予測されており、予測期間中のCAGRは%です。
本レポートは、業界標準の正確な分析と高いデータ保全性により、世界の患者用医薬品市場で得られる主要な機会を明らかにし、プレイヤーが市場での確固たる地位を獲得するために役立つことを目的としています。本レポートの購入者は、世界の患者用医薬品市場の全体的な規模（売上高）を含む、検証された信頼性の高い市場予測にアクセスすることができます。
全体として、本レポートは、プレイヤーが競合他社に対する競争力を獲得し、世界の患者用医薬品市場で永続的な成功を収めるために利用できる効果的なツールであることを証明しています。本レポートに掲載されているすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界の患者用医療製品市場を詳細に調査するために、ユニークで業界最高の調査・分析アプローチを採用しました。
世界の患者用医療製品の範囲と市場規模
患者用医療製品市場は、プレイヤー、地域（国）、タイプ、アプリケーション別に分類されます。世界の患者用健康製品市場のプレーヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるでしょう。セグメント別分析では、2017年から2028年までのタイプ別、アプリケーション別の収益と予測に焦点を当てています。
タイプ別セグメント
スキンケア製品
オーラルケア製品
栄養補助食品
創傷ケア製品
消化器系製品
用途別セグメント
病院薬剤師
個人薬局
オンライン販売
その他
会社別
ファイザー社
アメリカン・ヘルス
アボット・ラボラトリーズ
GlaxosmithKline plc
イプセン・コーポレート
バイエル株式会社
ピラマル・エンタープライズ社
サン・ファーマシューティカルズ社
グレンマーク・ファーマシューティカルズ・リミテッド
ジョンソン・アンド・ジョンソン
地域別
北アメリカ
アメリカ
カナダ
ヨーロッパ
ドイツ
フランス
イギリス
イタリア
ロシア
北欧諸国
その他のヨーロッパ諸国
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア諸国
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中近東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他の中東・アフリカ地域

ページTOPに戻る

目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Patient Health Products Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Skin Care Products
1.2.3 Oral Care Products
1.2.4 Nutritional Supplements
1.2.5 Wound Care Management Products
1.2.6 Gastrointestinal Products
1.3 Market by Application
1.3.1 Global Patient Health Products Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital Pharmacy
1.3.3 Independent Pharmacies
1.3.4 Online Sales
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Patient Health Products Market Perspective (2017-2028)
2.2 Patient Health Products Growth Trends by Region
2.2.1 Patient Health Products Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Patient Health Products Historic Market Size by Region (2017-2022)
2.2.3 Patient Health Products Forecasted Market Size by Region (2023-2028)
2.3 Patient Health Products Market Dynamics
2.3.1 Patient Health Products Industry Trends
2.3.2 Patient Health Products Market Drivers
2.3.3 Patient Health Products Market Challenges
2.3.4 Patient Health Products Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Patient Health Products Players by Revenue
3.1.1 Global Top Patient Health Products Players by Revenue (2017-2022)
3.1.2 Global Patient Health Products Revenue Market Share by Players (2017-2022)
3.2 Global Patient Health Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Patient Health Products Revenue
3.4 Global Patient Health Products Market Concentration Ratio
3.4.1 Global Patient Health Products Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Patient Health Products Revenue in 2021
3.5 Patient Health Products Key Players Head office and Area Served
3.6 Key Players Patient Health Products Product Solution and Service
3.7 Date of Enter into Patient Health Products Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Patient Health Products Breakdown Data by Type
4.1 Global Patient Health Products Historic Market Size by Type (2017-2022)
4.2 Global Patient Health Products Forecasted Market Size by Type (2023-2028)
5 Patient Health Products Breakdown Data by Application
5.1 Global Patient Health Products Historic Market Size by Application (2017-2022)
5.2 Global Patient Health Products Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Patient Health Products Market Size (2017-2028)
6.2 North America Patient Health Products Market Size by Type
6.2.1 North America Patient Health Products Market Size by Type (2017-2022)
6.2.2 North America Patient Health Products Market Size by Type (2023-2028)
6.2.3 North America Patient Health Products Market Share by Type (2017-2028)
6.3 North America Patient Health Products Market Size by Application
6.3.1 North America Patient Health Products Market Size by Application (2017-2022)
6.3.2 North America Patient Health Products Market Size by Application (2023-2028)
6.3.3 North America Patient Health Products Market Share by Application (2017-2028)
6.4 North America Patient Health Products Market Size by Country
6.4.1 North America Patient Health Products Market Size by Country (2017-2022)
6.4.2 North America Patient Health Products Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Patient Health Products Market Size (2017-2028)
7.2 Europe Patient Health Products Market Size by Type
7.2.1 Europe Patient Health Products Market Size by Type (2017-2022)
7.2.2 Europe Patient Health Products Market Size by Type (2023-2028)
7.2.3 Europe Patient Health Products Market Share by Type (2017-2028)
7.3 Europe Patient Health Products Market Size by Application
7.3.1 Europe Patient Health Products Market Size by Application (2017-2022)
7.3.2 Europe Patient Health Products Market Size by Application (2023-2028)
7.3.3 Europe Patient Health Products Market Share by Application (2017-2028)
7.4 Europe Patient Health Products Market Size by Country
7.4.1 Europe Patient Health Products Market Size by Country (2017-2022)
7.4.2 Europe Patient Health Products Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Patient Health Products Market Size (2017-2028)
8.2 Asia-Pacific Patient Health Products Market Size by Type
8.2.1 Asia-Pacific Patient Health Products Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Patient Health Products Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Patient Health Products Market Share by Type (2017-2028)
8.3 Asia-Pacific Patient Health Products Market Size by Application
8.3.1 Asia-Pacific Patient Health Products Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Patient Health Products Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Patient Health Products Market Share by Application (2017-2028)
8.4 Asia-Pacific Patient Health Products Market Size by Region
8.4.1 Asia-Pacific Patient Health Products Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Patient Health Products Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Patient Health Products Market Size (2017-2028)
9.2 Latin America Patient Health Products Market Size by Type
9.2.1 Latin America Patient Health Products Market Size by Type (2017-2022)
9.2.2 Latin America Patient Health Products Market Size by Type (2023-2028)
9.2.3 Latin America Patient Health Products Market Share by Type (2017-2028)
9.3 Latin America Patient Health Products Market Size by Application
9.3.1 Latin America Patient Health Products Market Size by Application (2017-2022)
9.3.2 Latin America Patient Health Products Market Size by Application (2023-2028)
9.3.3 Latin America Patient Health Products Market Share by Application (2017-2028)
9.4 Latin America Patient Health Products Market Size by Country
9.4.1 Latin America Patient Health Products Market Size by Country (2017-2022)
9.4.2 Latin America Patient Health Products Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Patient Health Products Market Size (2017-2028)
10.2 Middle East & Africa Patient Health Products Market Size by Type
10.2.1 Middle East & Africa Patient Health Products Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Patient Health Products Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Patient Health Products Market Share by Type (2017-2028)
10.3 Middle East & Africa Patient Health Products Market Size by Application
10.3.1 Middle East & Africa Patient Health Products Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Patient Health Products Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Patient Health Products Market Share by Application (2017-2028)
10.4 Middle East & Africa Patient Health Products Market Size by Country
10.4.1 Middle East & Africa Patient Health Products Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Patient Health Products Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Pfizer, Inc.
11.1.1 Pfizer, Inc. Company Details
11.1.2 Pfizer, Inc. Business Overview
11.1.3 Pfizer, Inc. Patient Health Products Introduction
11.1.4 Pfizer, Inc. Revenue in Patient Health Products Business (2017-2022)
11.1.5 Pfizer, Inc. Recent Developments
11.2 American Health
11.2.1 American Health Company Details
11.2.2 American Health Business Overview
11.2.3 American Health Patient Health Products Introduction
11.2.4 American Health Revenue in Patient Health Products Business (2017-2022)
11.2.5 American Health Recent Developments
11.3 Abbott Laboratories
11.3.1 Abbott Laboratories Company Details
11.3.2 Abbott Laboratories Business Overview
11.3.3 Abbott Laboratories Patient Health Products Introduction
11.3.4 Abbott Laboratories Revenue in Patient Health Products Business (2017-2022)
11.3.5 Abbott Laboratories Recent Developments
11.4 GlaxosmithKline plc
11.4.1 GlaxosmithKline plc Company Details
11.4.2 GlaxosmithKline plc Business Overview
11.4.3 GlaxosmithKline plc Patient Health Products Introduction
11.4.4 GlaxosmithKline plc Revenue in Patient Health Products Business (2017-2022)
11.4.5 GlaxosmithKline plc Recent Developments
11.5 Ipsen Corporate
11.5.1 Ipsen Corporate Company Details
11.5.2 Ipsen Corporate Business Overview
11.5.3 Ipsen Corporate Patient Health Products Introduction
11.5.4 Ipsen Corporate Revenue in Patient Health Products Business (2017-2022)
11.5.5 Ipsen Corporate Recent Developments
11.6 Bayer AG
11.6.1 Bayer AG Company Details
11.6.2 Bayer AG Business Overview
11.6.3 Bayer AG Patient Health Products Introduction
11.6.4 Bayer AG Revenue in Patient Health Products Business (2017-2022)
11.6.5 Bayer AG Recent Developments
11.7 Piramal Enterprises Ltd.
11.7.1 Piramal Enterprises Ltd. Company Details
11.7.2 Piramal Enterprises Ltd. Business Overview
11.7.3 Piramal Enterprises Ltd. Patient Health Products Introduction
11.7.4 Piramal Enterprises Ltd. Revenue in Patient Health Products Business (2017-2022)
11.7.5 Piramal Enterprises Ltd. Recent Developments
11.8 Sun Pharmaceuticals Ltd.
11.8.1 Sun Pharmaceuticals Ltd. Company Details
11.8.2 Sun Pharmaceuticals Ltd. Business Overview
11.8.3 Sun Pharmaceuticals Ltd. Patient Health Products Introduction
11.8.4 Sun Pharmaceuticals Ltd. Revenue in Patient Health Products Business (2017-2022)
11.8.5 Sun Pharmaceuticals Ltd. Recent Developments
11.9 Glenmark Pharmaceuticals Ltd.
11.9.1 Glenmark Pharmaceuticals Ltd. Company Details
11.9.2 Glenmark Pharmaceuticals Ltd. Business Overview
11.9.3 Glenmark Pharmaceuticals Ltd. Patient Health Products Introduction
11.9.4 Glenmark Pharmaceuticals Ltd. Revenue in Patient Health Products Business (2017-2022)
11.9.5 Glenmark Pharmaceuticals Ltd. Recent Developments
11.10 Johnson and Johnson
11.10.1 Johnson and Johnson Company Details
11.10.2 Johnson and Johnson Business Overview
11.10.3 Johnson and Johnson Patient Health Products Introduction
11.10.4 Johnson and Johnson Revenue in Patient Health Products Business (2017-2022)
11.10.5 Johnson and Johnson Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer